COU-1

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCOU-1
Drug Alias Nameanti-CaOU-1 MAb (Affitech/Natimmune)COU-1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorwayDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAffitech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAffitechAzanta Danmark A/S
Active IndicationsN/A
Inactive IndicationsColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A